Search Results

You are looking at 1 - 10 of 54 items for :

  • "malignant pleural mesothelioma" x
  • Refine by Access: All x
Clear All
Full access

Malignant Pleural Mesothelioma

David S. Ettinger, Wallace Akerley, Hossein Borghaei, Andrew Chang, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D'Amico, Todd L. Demmy, Apar Kishor P. Ganti, Ramaswamy Govindan, Frederic W. Grannis, Leora Horn, Thierry M. Jahan, Mohammad Jahanzeb, Anne Kessinger, Ritsuko Komaki, Feng-Ming (Spring) Kong, Mark G. Kris, Lee M. Krug, Inga T. Lennes, Billy W. Loo, Renato Martins, Janis O'Malley, Raymond U. Osarogiagbon, Gregory A. Otterson, Jyoti D. Patel, Mary Pinder Schenck, Katherine M. Pisters, Karen Reckamp, Gregory J. Riely, Eric Rohren, Scott J. Swanson, Douglas E. Wood, and Stephen C. Yang

mesothelioma (MPM), which is the most common type; mesothelioma can also occur in other sites (e.g., peritoneum, pericardium, tunica vaginalis testis). The disease is difficult to treat; NCCN Clinical Practice Guidelines in Oncology for Malignant Pleural

Full access

NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016

David S. Ettinger, Douglas E. Wood, Wallace Akerley, Lyudmila A. Bazhenova, Hossein Borghaei, David Ross Camidge, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D'Amico, Thomas Dilling, Michael Dobelbower, Ramaswamy Govindan, Mark Hennon, Leora Horn, Thierry M. Jahan, Ritsuko Komaki, Rudy P. Lackner, Michael Lanuti, Rogerio Lilenbaum, Jules Lin, Billy W. Loo Jr, Renato Martins, Gregory A. Otterson, Jyoti D. Patel, Katherine M. Pisters, Karen Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, Neelesh Sharma, Scott J. Swanson, James Stevenson, Kurt Tauer, Stephen C. Yang, Kristina Gregory, and Miranda Hughes

activity, participants will be able to: Integrate into professional practice the updates to NCCN Guidelines for Malignant Pleural Mesothelioma Describe the rationale behind the decision-making process for developing the NCCN Guidelines for Malignant

Full access

Photodynamic Therapy for Malignant Pleural Mesothelioma

Joseph S. Friedberg

Performing surgery for malignant pleural mesothelioma “is like scraping paint off a wall: there is always going to be microscopic disease left,” declared Joseph S. Friedberg, MD, Chief of Thoracic Surgery at Penn Presbyterian Medical Center

Full access

Novel Therapies in Phase II and III Trials for Malignant Pleural Mesothelioma

Marjorie G. Zauderer and Lee M. Krug

Background Malignant pleural mesothelioma (MPM) is a rare malignancy of the pleura that is usually associated with asbestos exposure. Although distant metastases can occur, mesothelioma typically spreads and invades locally. Unfortunately

Full access

CLO20-030: Sex-Based Disparities in Receipt of Care and Survival in Malignant Pleural Mesothelioma

Andrew R. Barsky, Christopher A. Ahern, Sriram Venigalla, Vivek Verma, Emily J. Anstadt, Christopher M. Wright, Ethan B. Ludmir, Christopher G. Berlind, William D. Lindsay, Surbhi Grover, Keith A. Cengel, and Charles B. Simone II

Purpose: Despite accounting for a minority of malignant pleural mesothelioma (MPM) diagnoses, females may experience differential survival relative to males. It is currently unclear if differences in receipt of treatment between sexes contribute to

Full access

NCCN News

. All registered users of NCCN.org recently received a complimentary preview of an NCCN Flash Updates notifying them that the NCCN Guidelines for Malignant Pleural Mesothelioma (MPM) was published as an addition to the Complete Library of NCCN

Full access

NCCN Guidelines® Insights: Mesothelioma: Pleural, Version 1.2024

Featured Updates to the NCCN Guidelines

James Stevenson, David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Debora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Malcolm DeCamp, Aakash Desai, Thomas J. Dilling, Jonathan Dowell, Gregory A. Durm, Marina C. Garassino, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo Jr, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Trey C. Mullikin, Thomas Ng, Gregory A. Otterson, Dawn Owen, Sandip P. Patel, Tejas Patil, Patricio M. Polanco, Gregory J. Riely, Jonathan Riess, Theresa A. Shapiro, Aditi P. Singh, Alda Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina Gregory, and Lisa Hang

United States and projection of future cases: an update based on SEER data for 1973 through 2005 . Crit Rev Toxicol 2009 ; 39 : 576 – 588 . 4. Tsao AS , Wistuba I , Roth JA , Malignant pleural mesothelioma . J Clin Oncol 2009 ; 27

Full access

NCCN News

regulatory status of agents used in cancer management, such as availabilities of drugs, biologics, devices, and procedures. New Malignant Pleural Mesothelioma Guidelines for Patients Available from NCCN NCCN, with the support of the NCCN Foundation

Full access

NCCN News

, Pancreatic, Prostate, and Stomach Cancers; Acute Lymphoblastic Leukemia; Adolescents and Young Adults with Cancer; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Hodgkin Lymphoma; Lung Cancer Screening; Malignant Pleural Mesothelioma; Melanoma

Full access

NCCN News

Young Adults; Chronic Myelogenous Leukemia; Malignant Pleural Mesothelioma; Melanoma; Multiple Myeloma; Lung Cancer Screening; and Soft Tissue Sarcoma. NCCN is committed to developing a comprehensive patient library with support from the NCCN